Production of KPC-2 alone does not always result in β-lactam MICs representing resistance in gram-negative pathogens

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 4183-4184

  Roth, Amanda L ^a   Thomson, Kenneth S ^a   Lister, Philip D ^a   Hanson, Nancy D ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; BETA LACTAMASE; BETA LACTAMASE KPC 2; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; ERTAPENEM; IMIPENEM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; STRUCTURAL GENE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

NEGIBACTERIA;

EID: 84869217341     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02194-12     Document Type: Letter

References (10)

1. Bratu S, et al. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 165:1430-1435. (Pubitemid 40973427)
2. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Daikos GL, et al. 2009. Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob. Agents Chemother. 53:1868-1873.
5. Kitchel B, et al. 2010. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:4201-4207.
6. Livermore DM, et al. 2012. Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J. Antimicrob. Chemother. 67:1569-1577.
7. Moland ES, Hong SG, Thomson KS, Larone DH, Hanson ND. 2007. Klebsiella pneumoniae isolate producing at least eight different β-lactamases, including AmpC and KPC β-lactamases. Antimicrob. Agents Chemother. 51:800-801. (Pubitemid 46185312)
8. KPC RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens. Antimicrob. Agents Chemother. 55:3936-3938.
9. Tenover FC, et al. 2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12:1209.
10. Yigit H, et al. 2001. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161. (Pubitemid 32230996)